![Lori McDermott](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lori McDermott worked as Vice President-Clinical Development at Scorpius Holdings, Inc. and as Chief Operating Officer at LumaBridge LLC.
She graduated from Drexel University College of Medicine with a graduate degree and from Neumann University with an undergraduate degree.
| Unternehmen | Position | Ende |
|---|---|---|
LumaBridge LLC
 LumaBridge LLC BiotechnologyHealth Technology Operates as a specialty clinical research organization that develops oncology focused clinical trial solutions for biotech companies | Geschäftsführer | 09.08.2023 |
| SCORPIUS HOLDINGS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 4 |
|---|---|
Scorpius Holdings, Inc.
 Scorpius Holdings, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of therapies | Health Technology |
Drexel University College of Medicine
 Drexel University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neumann University
 Neumann University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LumaBridge LLC
LumaBridge LLC BiotechnologyHealth Technology Operates as a specialty clinical research organization that develops oncology focused clinical trial solutions for biotech companies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
